American Century Companies’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,998
Closed -$28.6K 2822
2023
Q1
$28.6K Buy
2,998
+542
+22% +$5.17K ﹤0.01% 2653
2022
Q4
$83.3K Buy
2,456
+1,339
+120% +$45.4K ﹤0.01% 2487
2022
Q3
$54K Buy
+1,117
New +$54K ﹤0.01% 2396
2018
Q2
Sell
-5,937
Closed -$9.46M 1337
2018
Q1
$9.46M Buy
+5,937
New +$9.46M 0.01% 653
2015
Q4
Sell
-35,063
Closed -$5.76M 1358
2015
Q3
$5.76M Buy
35,063
+4,450
+15% +$732K 0.01% 789
2015
Q2
$5.75M Buy
+30,613
New +$5.75M 0.01% 797
2015
Q1
Sell
-21,808
Closed -$5.07M 1412
2014
Q4
$5.07M Buy
21,808
+556
+3% +$129K 0.01% 848
2014
Q3
$3.85M Buy
21,252
+695
+3% +$126K ﹤0.01% 942
2014
Q2
$3.95M Buy
20,557
+13,234
+181% +$2.54M ﹤0.01% 962
2014
Q1
$1.33M Buy
7,323
+1,674
+30% +$304K ﹤0.01% 1172
2013
Q4
$962K Buy
5,649
+343
+6% +$58.4K ﹤0.01% 1253
2013
Q3
$832K Buy
5,306
+337
+7% +$52.8K ﹤0.01% 1269
2013
Q2
$861K Buy
+4,969
New +$861K ﹤0.01% 1229